Day Range4.350 - 4.473 | 52 Wk Range3.510 - 6.510 | Open / Close4.490 / - | Float / Outstanding- / 24.935M |
Vol / Avg.10.165K / 23.076K | Mkt Cap110.529M | P/E- | 50d Avg. Price5.070 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.090 |
ImmunoPrecise Antibodies Stock (NASDAQ: IPA) stock price, news, charts, stock research, profile.
Day Range4.350 - 4.473 | 52 Wk Range3.510 - 6.510 | Open / Close4.490 / - | Float / Outstanding- / 24.935M |
Vol / Avg.10.165K / 23.076K | Mkt Cap110.529M | P/E- | 50d Avg. Price5.070 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-15 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | ||||||
REV | 3.840M | 3.898M | 58.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ImmunoPrecise Antibodies (NASDAQ: IPA) through any online brokerage.
There are no as such competitors for ImmunoPrecise Antibodies.
The latest price target for ImmunoPrecise Antibodies (NASDAQ: IPA) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 9.00 expecting IPA to rise to within 12 months (a possible 103.04% upside). 1 analyst firms have reported ratings in the last year.
The stock price for ImmunoPrecise Antibodies (NASDAQ: IPA) is $4.4326 last updated Today at January 31, 2023 at 5:41 PM UTC.
There are no upcoming dividends for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies’s Q3 earnings are confirmed for Wednesday, March 15, 2023.
There is no upcoming split for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ImmunoPrecise Antibodies Stock (NASDAQ: IPA) stock price, news, charts, stock research, profile.
Day Range4.350 - 4.473 | 52 Wk Range3.510 - 6.510 | Open / Close4.490 / - | Float / Outstanding- / 24.935M |
Vol / Avg.10.165K / 23.076K | Mkt Cap110.529M | P/E- | 50d Avg. Price5.070 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-15 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | ||||||
REV | 3.840M | 3.898M | 58.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ImmunoPrecise Antibodies (NASDAQ: IPA) through any online brokerage.
There are no as such competitors for ImmunoPrecise Antibodies.
The latest price target for ImmunoPrecise Antibodies (NASDAQ: IPA) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 9.00 expecting IPA to rise to within 12 months (a possible 103.04% upside). 1 analyst firms have reported ratings in the last year.
The stock price for ImmunoPrecise Antibodies (NASDAQ: IPA) is $4.4326 last updated Today at January 31, 2023 at 5:41 PM UTC.
There are no upcoming dividends for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies’s Q3 earnings are confirmed for Wednesday, March 15, 2023.
There is no upcoming split for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ImmunoPrecise Antibodies Stock (NASDAQ: IPA) stock price, news, charts, stock research, profile.
Day Range4.350 - 4.473 | 52 Wk Range3.510 - 6.510 | Open / Close4.490 / - | Float / Outstanding- / 24.935M |
Vol / Avg.10.165K / 23.076K | Mkt Cap110.529M | P/E- | 50d Avg. Price5.070 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-15 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | ||||||
REV | 3.840M | 3.898M | 58.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ImmunoPrecise Antibodies (NASDAQ: IPA) through any online brokerage.
There are no as such competitors for ImmunoPrecise Antibodies.
The latest price target for ImmunoPrecise Antibodies (NASDAQ: IPA) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 9.00 expecting IPA to rise to within 12 months (a possible 103.04% upside). 1 analyst firms have reported ratings in the last year.
The stock price for ImmunoPrecise Antibodies (NASDAQ: IPA) is $4.4326 last updated Today at January 31, 2023 at 5:41 PM UTC.
There are no upcoming dividends for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies’s Q3 earnings are confirmed for Wednesday, March 15, 2023.
There is no upcoming split for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ImmunoPrecise Antibodies Stock (NASDAQ: IPA) stock price, news, charts, stock research, profile.
Day Range4.350 - 4.473 | 52 Wk Range3.510 - 6.510 | Open / Close4.490 / - | Float / Outstanding- / 24.935M |
Vol / Avg.10.165K / 23.076K | Mkt Cap110.529M | P/E- | 50d Avg. Price5.070 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-15 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | ||||||
REV | 3.840M | 3.898M | 58.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ImmunoPrecise Antibodies (NASDAQ: IPA) through any online brokerage.
There are no as such competitors for ImmunoPrecise Antibodies.
The latest price target for ImmunoPrecise Antibodies (NASDAQ: IPA) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 9.00 expecting IPA to rise to within 12 months (a possible 103.04% upside). 1 analyst firms have reported ratings in the last year.
The stock price for ImmunoPrecise Antibodies (NASDAQ: IPA) is $4.4326 last updated Today at January 31, 2023 at 5:41 PM UTC.
There are no upcoming dividends for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies’s Q3 earnings are confirmed for Wednesday, March 15, 2023.
There is no upcoming split for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ImmunoPrecise Antibodies Stock (NASDAQ: IPA) stock price, news, charts, stock research, profile.
Day Range4.350 - 4.473 | 52 Wk Range3.510 - 6.510 | Open / Close4.490 / - | Float / Outstanding- / 24.935M |
Vol / Avg.10.165K / 23.076K | Mkt Cap110.529M | P/E- | 50d Avg. Price5.070 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-15 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | ||||||
REV | 3.840M | 3.898M | 58.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ImmunoPrecise Antibodies (NASDAQ: IPA) through any online brokerage.
There are no as such competitors for ImmunoPrecise Antibodies.
The latest price target for ImmunoPrecise Antibodies (NASDAQ: IPA) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 9.00 expecting IPA to rise to within 12 months (a possible 103.04% upside). 1 analyst firms have reported ratings in the last year.
The stock price for ImmunoPrecise Antibodies (NASDAQ: IPA) is $4.4326 last updated Today at January 31, 2023 at 5:41 PM UTC.
There are no upcoming dividends for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies’s Q3 earnings are confirmed for Wednesday, March 15, 2023.
There is no upcoming split for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ImmunoPrecise Antibodies Stock (NASDAQ: IPA) stock price, news, charts, stock research, profile.
Day Range4.350 - 4.473 | 52 Wk Range3.510 - 6.510 | Open / Close4.490 / - | Float / Outstanding- / 24.935M |
Vol / Avg.10.165K / 23.076K | Mkt Cap110.529M | P/E- | 50d Avg. Price5.070 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-15 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | ||||||
REV | 3.840M | 3.898M | 58.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ImmunoPrecise Antibodies (NASDAQ: IPA) through any online brokerage.
There are no as such competitors for ImmunoPrecise Antibodies.
The latest price target for ImmunoPrecise Antibodies (NASDAQ: IPA) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 9.00 expecting IPA to rise to within 12 months (a possible 103.04% upside). 1 analyst firms have reported ratings in the last year.
The stock price for ImmunoPrecise Antibodies (NASDAQ: IPA) is $4.4326 last updated Today at January 31, 2023 at 5:41 PM UTC.
There are no upcoming dividends for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies’s Q3 earnings are confirmed for Wednesday, March 15, 2023.
There is no upcoming split for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ImmunoPrecise Antibodies Stock (NASDAQ: IPA) stock price, news, charts, stock research, profile.
Day Range4.350 - 4.473 | 52 Wk Range3.510 - 6.510 | Open / Close4.490 / - | Float / Outstanding- / 24.935M |
Vol / Avg.10.165K / 23.076K | Mkt Cap110.529M | P/E- | 50d Avg. Price5.070 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-15 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | ||||||
REV | 3.840M | 3.898M | 58.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ImmunoPrecise Antibodies (NASDAQ: IPA) through any online brokerage.
There are no as such competitors for ImmunoPrecise Antibodies.
The latest price target for ImmunoPrecise Antibodies (NASDAQ: IPA) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 9.00 expecting IPA to rise to within 12 months (a possible 103.04% upside). 1 analyst firms have reported ratings in the last year.
The stock price for ImmunoPrecise Antibodies (NASDAQ: IPA) is $4.4326 last updated Today at January 31, 2023 at 5:41 PM UTC.
There are no upcoming dividends for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies’s Q3 earnings are confirmed for Wednesday, March 15, 2023.
There is no upcoming split for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ImmunoPrecise Antibodies Stock (NASDAQ: IPA) stock price, news, charts, stock research, profile.
Day Range4.350 - 4.473 | 52 Wk Range3.510 - 6.510 | Open / Close4.490 / - | Float / Outstanding- / 24.935M |
Vol / Avg.10.165K / 23.076K | Mkt Cap110.529M | P/E- | 50d Avg. Price5.070 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-15 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | ||||||
REV | 3.840M | 3.898M | 58.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ImmunoPrecise Antibodies (NASDAQ: IPA) through any online brokerage.
There are no as such competitors for ImmunoPrecise Antibodies.
The latest price target for ImmunoPrecise Antibodies (NASDAQ: IPA) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 9.00 expecting IPA to rise to within 12 months (a possible 103.04% upside). 1 analyst firms have reported ratings in the last year.
The stock price for ImmunoPrecise Antibodies (NASDAQ: IPA) is $4.4326 last updated Today at January 31, 2023 at 5:41 PM UTC.
There are no upcoming dividends for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies’s Q3 earnings are confirmed for Wednesday, March 15, 2023.
There is no upcoming split for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
ImmunoPrecise Antibodies Stock (NASDAQ: IPA) stock price, news, charts, stock research, profile.
Day Range4.350 - 4.473 | 52 Wk Range3.510 - 6.510 | Open / Close4.490 / - | Float / Outstanding- / 24.935M |
Vol / Avg.10.165K / 23.076K | Mkt Cap110.529M | P/E- | 50d Avg. Price5.070 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.090 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-15 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | ||||||
REV | 3.840M | 3.898M | 58.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ImmunoPrecise Antibodies (NASDAQ: IPA) through any online brokerage.
There are no as such competitors for ImmunoPrecise Antibodies.
The latest price target for ImmunoPrecise Antibodies (NASDAQ: IPA) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 9.00 expecting IPA to rise to within 12 months (a possible 103.04% upside). 1 analyst firms have reported ratings in the last year.
The stock price for ImmunoPrecise Antibodies (NASDAQ: IPA) is $4.4326 last updated Today at January 31, 2023 at 5:41 PM UTC.
There are no upcoming dividends for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies’s Q3 earnings are confirmed for Wednesday, March 15, 2023.
There is no upcoming split for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.